{"database": "lobbying", "table": "lobbying_activities", "rows": [[1448040, "1bd63e40-f477-4723-be0d-35b9df946328", "Q3", "LIFE TECHNOLOGIES CORPORATION", 400391833, "LIFE TECHNOLOGIES CORPORATION", 2013, "third_quarter", "MED", "H.R. 3005: Medical Testing Availablity Act of 2013; Provisions regarding FDA regulations of certain diagnostics and lab developed tests.\nDraft guidance regarding commercially distributed in vitro diagnostic products labeled \"For Research Only or Investigational Use Only:\" Frequently Asked Questions; Provisions regarding regulation of certain diagnostics.H.R. 2085: Diagnostic Innovation Testing and Knowledge Advancement Act of 2013; Provisions regarding value based payment for advanced diagnostics.", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", null, 70000, 0, 0, "2013-10-17T15:58:58.717000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1448040"], "units": {}, "query_ms": 40.81741499248892, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}